The Clorox Company (NYSE:CLX) Shares Sold by Bigelow Investment Advisors LLC

Bigelow Investment Advisors LLC cut its holdings in The Clorox Company (NYSE:CLXFree Report) by 4.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 1,923 shares of the company’s stock after selling 90 shares during the period. Bigelow Investment Advisors LLC’s holdings in Clorox were worth $274,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Tyler Stone Wealth Management purchased a new stake in Clorox during the 2nd quarter worth $25,000. Strategic Investment Solutions Inc. IL bought a new position in shares of Clorox during the first quarter worth about $31,000. Fortitude Family Office LLC bought a new position in shares of Clorox during the fourth quarter worth about $29,000. First Capital Advisors Group LLC. bought a new position in shares of Clorox during the second quarter worth about $35,000. Finally, Hartford Financial Management Inc. raised its stake in Clorox by 57.1% during the fourth quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock worth $37,000 after acquiring an additional 93 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Up 0.3 %

NYSE:CLX opened at $143.58 on Friday. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $178.21. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The stock has a market cap of $17.82 billion, a price-to-earnings ratio of 227.91, a PEG ratio of 2.26 and a beta of 0.43. The stock has a 50-day moving average price of $149.99 and a two-hundred day moving average price of $141.79.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The firm had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the previous year, the firm earned $0.98 earnings per share. The company’s revenue was up 16.0% on a year-over-year basis. As a group, equities analysts expect that The Clorox Company will post 5.52 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be paid a $1.20 dividend. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.34%. Clorox’s payout ratio is 761.92%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. DA Davidson reiterated a “neutral” rating and set a $162.00 price target on shares of Clorox in a research report on Wednesday. The Goldman Sachs Group started coverage on Clorox in a research report on Friday, March 1st. They issued a “sell” rating and a $140.00 price target for the company. JPMorgan Chase & Co. increased their price target on Clorox from $145.00 to $152.00 and gave the company a “neutral” rating in a research report on Thursday, January 18th. Morgan Stanley reiterated an “equal weight” rating and issued a $160.00 price target on shares of Clorox in a research report on Tuesday, March 26th. Finally, Citigroup reduced their price objective on Clorox from $165.00 to $155.00 and set a “neutral” rating for the company in a research note on Tuesday. Four investment analysts have rated the stock with a sell rating and thirteen have given a hold rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $148.63.

Get Our Latest Report on Clorox

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.